NCT00430469View on ClinicalTrials.gov

Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients

PHASE1/PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

November 30, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

June 30, 2009

Conditions

Fungal InfectionBacterial Infection

Interventions

DRUG

human lactoferrin (hLF1-11)

intravenous 0.5mg in NaCl-solution

Trial Locations (1)

6500 HB

UMC St. Radboud, Nijmegen

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AM-Pharma

INDUSTRY